TELA Bio, Inc. (TELA)

TELA Bio Statistics

Total Valuation

TELA Bio has a market cap or net worth of $48.25 million. The enterprise value is $39.23 million.

Market Cap	48.25M
Enterprise Value	39.23M

Important Dates

The last earnings date was Thursday, March 20, 2025, after market close.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

TELA Bio has 39.55 million shares outstanding. The number of shares has increased by 24.74% in one year.

Current Share Class	39.55M
Shares Outstanding	39.55M
Shares Change (YoY)	+24.74%
Shares Change (QoQ)	+62.22%
Owned by Insiders (%)	7.94%
Owned by Institutions (%)	35.25%
Float	20.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.51
Forward PS	0.54
PB Ratio	1.71
P/TBV Ratio	1.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.57
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.01, with a Debt / Equity ratio of 1.51.

Current Ratio	5.01
Quick Ratio	4.02
Debt / Equity	1.51
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.88

Financial Efficiency

Return on equity (ROE) is -159.87% and return on invested capital (ROIC) is -39.14%.

Return on Equity (ROE)	-159.87%
Return on Assets (ROA)	-31.66%
Return on Invested Capital (ROIC)	-39.14%
Return on Capital Employed (ROCE)	-58.75%
Revenue Per Employee	$305,286
Profits Per Employee	-$166,700
Employee Count	227
Asset Turnover	0.84
Inventory Turnover	1.73

Taxes

Income Tax	-144,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -77.99% in the last 52 weeks. The beta is 1.10, so TELA Bio's price volatility has been similar to the market average.

Beta (5Y)	1.10
52-Week Price Change	-77.99%
50-Day Moving Average	2.42
200-Day Moving Average	3.11
Relative Strength Index (RSI)	20.75
Average Volume (20 Days)	427,201

Short Selling Information

The latest short interest is 446,362, so 1.13% of the outstanding shares have been sold short.

Short Interest	446,362
Short Previous Month	467,842
Short % of Shares Out	1.13%
Short % of Float	2.17%
Short Ratio (days to cover)	2.80

Income Statement

In the last 12 months, TELA Bio had revenue of $69.30 million and -$37.84 million in losses. Loss per share was -$1.33.

Revenue	69.30M
Gross Profit	46.87M
Operating Income	-41.70M
Pretax Income	-40.30M
Net Income	-37.84M
EBITDA	-40.68M
EBIT	-41.70M
Loss Per Share	-$1.33

Balance Sheet

The company has $52.67 million in cash and $43.06 million in debt, giving a net cash position of $9.61 million or $0.24 per share.

Cash & Cash Equivalents	52.67M
Total Debt	43.06M
Net Cash	9.61M
Net Cash Per Share	$0.24
Equity (Book Value)	28.46M
Book Value Per Share	0.72
Working Capital	62.47M

Cash Flow

Operating Cash Flow	-41.60M
Capital Expenditures	-989,000
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 67.63%, with operating and profit margins of -60.17% and -54.60%.

Gross Margin	67.63%
Operating Margin	-60.17%
Pretax Margin	-54.81%
Profit Margin	-54.60%
EBITDA Margin	-58.71%
EBIT Margin	-60.17%
FCF Margin	n/a

Dividends & Yields

TELA Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.74%
Shareholder Yield	n/a
Earnings Yield	-77.47%
FCF Yield	n/a

Analyst Forecast

The average price target for TELA Bio is $6.00, which is 391.80% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	391.80%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	25.53%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TELA Bio has an Altman Z-Score of -4.51 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.51
Piotroski F-Score	2